R Squared’s AngioDynamics ANGO Stock Holding History

R Squared’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,206	Closed	-$298K	–	490
2025 Q4	$298K	Buy	23,206 +4,080	+21%	+$50.4K	0.14%	230
2025 Q3	$214K	Buy	+19,126	New	+$185K	0.09%	363
2025 Q1	–	Sell	-5,371	Closed	-$49.2K	–	356
2024 Q4	$49.2K	Buy	+5,371	New	+$39.5K	0.05%	499

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

R Squared's ANGO Position: Q1 2026 in Review

R Squared sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 23,206 shares — an estimated $298K sold.

R Squared first reported a position in ANGO in Q4 2024 and held it in 3 quarters. The position peaked at $298K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

R Squared reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
R Squared sold 23,206 AngioDynamics shares in Q1 2026, an estimated $298K.
R Squared first reported a position in AngioDynamics in Q4 2024 and held it in 3 quarters.
R Squared's AngioDynamics position peaked at $298K in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.